Molecular Chaperones in Cancer and Protein Quality Control Frontiers in Immunomodulation and Cancer Therapy (2nd edition)

Inicio | Eventos | Functional validation of DNA glycosylases as cancer risk modifiers in BRCA1 and BRCA2 mutation carriers. Potential use of OGG1 inhibitors as a novel strategy for cancer treatment

Functional validation of DNA glycosylases as cancer risk modifiers in BRCA1 and BRCA2 mutation carriers. Potential use of OGG1 inhibitors as a novel strategy for cancer treatment

Información

Fecha: 29/01/2021
Hora 11:00
Lugar: Online
Conferenciante Juan Miguel Baquero
Procedencia Human Genetics Group, Human Cancer Genetics Programme
Supervised by Javier Benítez and Ana Osorio, Human Genetics Group, Human Cancer Genetics Programme
Entrada libre hasta completar aforo

Subir